Your browser doesn't support javascript.
loading
Assessment of Tumor Volume Dynamics and Outcome After Radiosurgery for the Treatment of Vestibular Schwannoma: A Single-Center Experience.
Ermis, Ekin; Egger, Riccarda; Leiser, Dominic; Anschuetz, Lukas; Raabe, Andreas; Abu-Isa, Janine; Manser, Peter; Aebersold, Daniel M; Wagner, Franca; Herrmann, Evelyn.
Affiliation
  • Ermis E; Department of Radiation Oncology.
  • Egger R; Department of Radiation Oncology.
  • Leiser D; Department of Radiation Oncology.
  • Anschuetz L; Department of Otorhinolaryngology, Head and Neck Surgery.
  • Raabe A; Department of Neurosurgery.
  • Abu-Isa J; Department of Neurosurgery.
  • Manser P; Division of Medical Radiation Physics, Department of Radiation Oncology.
  • Aebersold DM; Department of Radiation Oncology.
  • Wagner F; Department of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, and University of Bern, Switzerland.
  • Herrmann E; Department of Radiation Oncology.
Otol Neurotol ; 42(6): e750-e757, 2021 07 01.
Article in En | MEDLINE | ID: mdl-34111052
ABSTRACT

OBJECTIVE:

To assess the factors affecting early local and audiometric outcomes in vestibular schwannoma (VS) patients treated with stereotactic radiosurgery (SRS). STUDY

DESIGN:

A retrospective review of medical records.

SETTING:

Tertiary referral center. PATIENTS Records of all adult patients who underwent SRS between 2010 and 2016 for the treatment of VS were retrospectively reviewed. Patients treated with microsurgery or multi-fractionation schemes, and those who had neurofibromatosis type 2, were excluded. INTERVENTION SRS, tumor volume/size measurements. MAIN OUTCOME

MEASURES:

The impact of tumor volume dynamics on the early local and hearing-related outcomes, together with the factors that influence them following SRS, and comparison of different tumor size measurement methods.

RESULTS:

From 2010 to 2016, 53 patients underwent single fraction SRS of 12 Gy. Median follow-up time was 32 months (range, 6-79). At the last follow-up, only one patient had clinical progression. Age less than or equal to 65 years (p = 0.04; odds ratio [OR] 0.17; 95% confidence interval [CI] 0.03-0.93) and baseline pure-tone average (PTA) level less than or equal to 30 dB (p = 0.03; OR 0.90; 95% CI 0.84-0.96) were associated with maintenance of serviceable hearing. On multivariate analysis, PTA remained significant (p = 0.01; OR 0.04; 95% CI 0.003-0.45). In patients with a loss of serviceable hearing, the mean volume increase tended to be higher than in the patients whose hearing was maintained. The linear measurement method underestimated, and the A × B × C/2 equation overestimated, the radiological progression compared with 3D-volumetric delineations.

CONCLUSION:

During the median observation period of almost 3 years, we reported our early outcome results. Tumor volume increase may have an impact on serviceable hearing loss after SRS. Currently there is no widely accepted method for the evaluation of post-SRS response. Linear measurement and the A × B × C/2 equation produce less reliable estimates of radiological progression compared with 3D-volumetric delineations. Accurate volume measurements with 3D delineations should be considered as part of clinical routine for assessing progression and deciding on salvage therapies.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroma, Acoustic / Radiosurgery Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Otol Neurotol Journal subject: NEUROLOGIA / OTORRINOLARINGOLOGIA Year: 2021 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuroma, Acoustic / Radiosurgery Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Otol Neurotol Journal subject: NEUROLOGIA / OTORRINOLARINGOLOGIA Year: 2021 Document type: Article